Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.

Lee, Jangsoon; Lim, Bora; Pearson, Troy; Choi, Kuicheon; Fuson, Jon A; Bartholomeusz, Chandra; Paradiso, Linda J; Myers, Thomas; Tripathy, Debu; Ueno, Naoto T

Lee, Jangsoon; Lim, Bora; Pearson, Troy; Choi, Kuicheon; Fuson, Jon A; Bartholomeusz, Chandra; Paradiso, Linda J; Myers, Thomas; Tripathy, Debu; Ueno, Naoto T.

Afiliação

Lee J; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.
Lim B; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX, 77030-4009, USA.
Pearson T; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.
Choi K; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX, 77030-4009, USA.
Fuson JA; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.
Bartholomeusz C; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.
Paradiso LJ; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.
Myers T; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.
Tripathy D; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX, 77030-4009, USA.
Ueno NT; Spirita Oncology, LLC, Natick, MA, USA.

Breast Cancer Res Treat ; 176(1): 251, 2019 Jul.

Article em En | MEDLINE | ID: mdl-30982934

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google